Jefferies Group LLC - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$26,000
+8.3%
100,0000.0%0.00%
Q1 2016$24,000
-31.4%
100,0000.0%0.00%
Q4 2015$35,000
-79.9%
100,0000.0%0.00%
-100.0%
Q3 2015$174,000
-97.2%
100,000
-96.9%
0.00%
-97.1%
Q1 2015$6,286,000
+132.0%
3,240,000
+260.0%
0.04%
+84.2%
Q3 2014$2,709,000
+160.0%
900,000
+445.5%
0.02%
+90.0%
Q3 2013$1,042,000164,9800.01%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders